Synthesis and COX-2 inhibitory activities of rutaecarpine homologues

Heterocycles

Volumn 60, Issue 6, 2003, Pages 1359-1366

  Chang, Hyeun Wook ^a   Kim, Seung Ill ^a   Jung, Hejin ^a   Jahng, Yurngdong ^a  

^a Yeungnam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 POLYMETHYLENE 4(3H) QUINAZOLINONE; 7,12 DIHYDROINDOLO[2',3':3,4]PYRROLO[2,1 B]QUINAZOLIN 5 ONE; 7,8,9,14 TETRAHYDRO 5H INDOLO[2',3':3,4]AZEPINO[2,1 B]QUINAZOLIN 5 ONE; CARBENE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOLE DERIVATIVE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; QUINAZOLINONE DERIVATIVE; RUTAECARPINE; RUTAECARPINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CONFORMATION; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; MELTING POINT; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0038485774     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-03-9744     Document Type: Article

References (23)

1. Y. Ashima and K. Kashiwaki, J. Pharm. Soc. Jpn., 1915, 35, 1293.
2. J. H. Chu, Science Record (China) 1951, 4, 479 (Chem. Abstr., 1952, 46, 11589b).
3. J. H. Chu, Science Record (China) 1951, 4, 479 (Chem. Abstr., 1952, 46, 11589b).
4. T. C. Moon, M. Murakami, I. Kudo, K. H. Son, H. P. Kim, S. S. Kang, and H. W. Chang, Inflamm. Res., 1999, 48, 621.
5. a) W. F. Chiou, C. J. Chou, J. F. Liao, A. Y. Sham, and C. F. Chen, Eur. J. Pharmacol., 1994, 257, 59.
6. b) G. J. Wang, X. C. Wu, C. F. Chen, L. C. Lin, Y. T. Huang, J. Shan, and P. K. Pang, J. Pharmacol. Exp. Ther., 1999, 289, 1237.
7. Y. C. Kong, H. A. Hu, F. K. Lau, C. T. Che, H. W. Yeng, S. Cheng, and C. C. Hwang, Am. J. Chin. Med., 1976, 4, 105.
8. W. S. Sheen, I. L. Tsai, C. M. Teng, F. N. Ko, and I. S. Chen, Planta Med., 1996, 62, 175.
9. L.-M. Yang, C.-F. Chen, and K.-H. Lee, Bioorg. Med. Chem. Lett., 1995, 5, 465.
10. a) Y. Asahima, R. H. F. Manske, and R. Robinson, J. Chem. Soc., 1927, 1708.
11. b) M. Yamazaki and A. Ikuta, Tetrahedron Lett., 1966, 3221.
12. c) T. Kametani, C. V. Loc, M. Higa, M. Koizumi, M. Ihara, and K. Fukumoto, J. Am. Chem. Soc., 1977, 99, 2306.
13. d) J. Bergman and S. Bergman, Heterocycles, 1981, 16, 347.
14. e) J. Kökösi, I. Hermecz, G. Szász, and Z. Mészáros, Tetrahedron Lett., 1981, 22, 4861.
15. f) S. H. Lee, S. I. Kim, J. G. Park, E. S. Lee, and Y. Jahng, Heterocycles, 2001, 55, 1555.
16. g) P. K. Mohanta and K. Kim, Terahedron Lett., 2002, 43, 3993.
17. Assignments of 2aa and 2ab are based on the following NOE spectral data: equation presented
18. rd 1987 (Meeting Date 1985), 5, 332, VCH, Weinheim, Germany. These compounds were described without any physical and spectral data.
19. R. G. Glushkov, T. K. Trubitsyna, O. Y. Magidson, and M. D. Mashkovski, Khim.-Farm. Zh., 1970, 4, 9. Title compound was prepared by reacting 1-ethoxy-4,5-dihydroxy-3H-azepino[3,4-b]indole and anthranilic acid.
20. The mp's of 3,3′-mono-, di-, and trimethylene-2,2′-bipyridines are 172 °C, 152-153 °C, and 141 °C, respectively: R. P. Thummel, F. Lefoulon, and R. Mahadevan, J. Org. Chem., 1985, 50, 3824.
21. a) W. E. Handford and R. Adams, J. Am. Chem. Soc., 1935, 57, 921.
22. b) P. Molina, A. Tarraga, and A. Gonzalez-Tejero, Synthesis, 2000, 11, 1523, where described only as a mixture of the two isomers.
23. Prepared by oxidizing corresponding hydroxy compound. T. R. Kelly, S. Chamberland, and R. A. Silva, Tetrahedron Lett., 1999, 40, 2723.